Literature DB >> 2982732

Suppression of delayed-type hypersensitivity mediated by macrophage-like cells in mice with experimental liver injury.

S Tajima, N Nishimura, K Ito.   

Abstract

The intensity of picryl chloride-induced delayed-type hypersensitivity (PCl-DTH) was significantly lowered in mice with experimental liver injury induced by the injection of carbon tetrachloride (CCl4) or 1-naphthylisothiocyanate (ANIT). Adherent spleen cells prepared from mice with liver injury suppressed the PCl-DTH in normal syngeneic mice by adoptive transfer at the time of immunization with picryl chloride (PCl). Cianidanol, administered orally to recipient mice immediately after the transfer of adherent spleen cells, caused total prevention of the PCl-DTH from suppression by the transferred adherent spleen cells. In in vitro studies, the adherent spleen cells from both CCl4-treated and ANIT-treated mice produced higher amounts of prostaglandin E2 (PGE2) than those from normal mice. The addition of cianidanol at the beginning of incubation caused an inhibition of PGE2 production of the adherent spleen cells. Furthermore, the spleen cell suspensions from CCl4-treated mice gave a marked increase in generation of superoxide anions (O2-), also inhibited by the addition of cianidanol. Gathered results support the adherent spleen cell as being the cell causing the suppression of DTH in mice with experimental liver injury; the important role of PGE2 and O2- in the suppression of DTH mediated by the adherent spleen cells was demonstrated. Cianidanol eliminated the suppression of DTH, owing principally to the inhibitory effect on the production of PGE2 and O2- from the adherent spleen cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2982732      PMCID: PMC1454857     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  23 in total

1.  Reticuloendothelial response to carbon tetrachloride.

Authors:  Z T WIRTSCHAFTER; M G DEMERITT
Journal:  AMA Arch Pathol       Date:  1959-02

2.  Suppressor cell activity in tumor-bearing mice. I. Dualistic inhibition by suppressor T lymphocytes and macrophages.

Authors:  K D Elgert; W L Farrar
Journal:  J Immunol       Date:  1978-04       Impact factor: 5.422

3.  Depressed in vitro peripheral blood lymphocyte response to mitogens in cancer patients: the role of suppressor cells.

Authors:  M Zembala; B Mytar; T Popiela; G L Asherson
Journal:  Int J Cancer       Date:  1977-05-15       Impact factor: 7.396

4.  Prostaglandin-producing suppressor cells in Hodgkin's disease.

Authors:  J S Goodwin; R P Messner; A D Bankhurst; G T Peake; J H Saiki; R C Williams
Journal:  N Engl J Med       Date:  1977-11-03       Impact factor: 91.245

5.  Macrophage-like suppressor cells in rats. II. Evidence for a quantitative rather than a qualitative change in tumour-bearer animals.

Authors:  P J Webb; C G Brooks; R W Baldwin
Journal:  Cell Immunol       Date:  1980-07-01       Impact factor: 4.868

6.  Effect of cianidanol (KB-53) on the activity of mouse cytotoxic-T-lymphocytes.

Authors:  Y Ikeda; K Kawakami; I Sato; S Tajima; K Ito; T Nose
Journal:  J Pharmacobiodyn       Date:  1984-01

7.  [Effects of cianidanol on chronic liver injury induced by carbon tetrachloride and on liver regeneration after partial hepatectomy in rats].

Authors:  I Sato; H Takebe; S Tajima; Y Ikeda; K Ito; T Nose
Journal:  Nihon Yakurigaku Zasshi       Date:  1983-06

8.  Effect of cianidanol (KB-53) on the activity of mouse natural killer cells.

Authors:  Y Ikeda; K Kawakami; I Sato; S Tajima; K Ito; T Nose
Journal:  J Pharmacobiodyn       Date:  1984-01

9.  Impaired cell-mediated immunity in Hodgkin's disease mediated by suppressor lymphocytes and monocytes.

Authors:  S M Hillinger; G P Herzig
Journal:  J Clin Invest       Date:  1978-06       Impact factor: 14.808

10.  Suppression of human T-cell mitogenesis by prostaglandin. Existence of a prostaglandin-producing suppressor cell.

Authors:  J S Goodwin; A D Bankhurst; R P Messner
Journal:  J Exp Med       Date:  1977-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.